<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04048499</url>
  </required_header>
  <id_info>
    <org_study_id>425</org_study_id>
    <nct_id>NCT04048499</nct_id>
  </id_info>
  <brief_title>Prevalence and Severity of Colour Vision Deficiency Among Turkish Children</brief_title>
  <official_title>Prevalence and Severity of Colour Vision Deficiency Among Turkish Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medipol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medipol University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the usability of the Colour Assessment and Diagnosis (CAD) test in children. To
      determine the prevalence of colour vision deficiency (CVD) among Turkish children, to
      identify the class of deficiency and to quanify severity of loss.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence and Severity of Colour Vision Deficiency among Turkish Children</measure>
    <time_frame>january 2018-march 2019</time_frame>
    <description>number of children with colour vision deficiency (CVD) among Turkish children who attend to the clinic in a period o time, number of children in each class of deficiency (protan, deutan) and number of children in each category according to severity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the usability of the Colour Assessment and Diagnosis (CAD) test in children</measure>
    <time_frame>january 2018-march 2019</time_frame>
    <description>number of children who were cooperative and carried out the full CAD test</description>
  </primary_outcome>
  <enrollment type="Actual">1374</enrollment>
  <condition>CAD Test; Children's Vision; Colour Assessment; Colour Vision; Turkey</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>the Colour Assessment and Diagnosis (CAD) test</intervention_name>
    <description>The CAD test (City Occupational Ltd, London, UK) measures the severity of red-green and yellow-blue colour vision loss according to red-green and yellow-blue thresholds which are expressed in CAD units and diagnoses accurately the subject's class of colour vision</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 1374 children, aged 6-16 years, who attended the ophthalmology department at the
        Istanbul Medipol University were included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: children with aged 6-16 years, who attended the ophthalmology
        department at the Istanbul Medipol University -

        Exclusion Criteria:Children with known or current evidence of ocular pathology (other than
        refractive errors), with history of long term use of medication, previous ocular surgery
        and those with chronic systemic diseases were excluded from the study

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istanbul Medipol University</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 6, 2019</study_first_submitted>
  <study_first_submitted_qc>August 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2019</study_first_posted>
  <last_update_submitted>August 7, 2019</last_update_submitted>
  <last_update_submitted_qc>August 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medipol University</investigator_affiliation>
    <investigator_full_name>Funda Dikkaya</investigator_full_name>
    <investigator_title>asist proffesor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Color Vision Defects</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

